IPF-017

Idiopathic Pulmonary Fibrosis (IPF)

罗切斯特 72 years old male United States Total Cost: 201

Patient Condition

The patient visited the hospital for 18 months due to shortness of breath gradually worsening after exercise and had a previous history of smoking (30 pack-years). HRCT showed typical UIP findings: honeycomb lungs dominated by the base of both lungs and traction bronchiectasis. Lung function: FVC 52% predicted, DLCO 35% predicted. 6MWD 280m, mMRC score 3. IPF was diagnosed after multidisciplinary discussions.

Treatment Timeline

PhaseDetailsDate
multidisciplinary diagnosis
treatment initiation
Treatment monitoring (months 1-12)
Long-term maintenance (months 13-24)

Treatment Outcome

beforeFVC accounted for 52% of predicted value, DLCO accounted for 35% of predicted value, 6MWD 280m, mMRC score 3
afterAfter 24 months of treatment, FVC accounted for 46% of the predicted value (annual decline rate of approximately 3%), DLCO accounted for 29% of the predicted value, 6MWD was 290m, and mMRC score was 3. Lung rehabilitation training improves exercise tolerance
highlight24-month treatment with nintedanib delayed the decline in FVC, improved 6MWD by 10m after combined lung rehabilitation training, and reduced the frequency of acute exacerbations